Literature DB >> 29556851

Novel Interventional Nonopioid Therapies in Headache Management.

Omar Viswanath1, Roxanna Rasekhi2, Rekhaben Suthar3, Mark R Jones1, Jacquelin Peck4, Alan D Kaye5.   

Abstract

PURPOSE OF REVIEW: Headaches encompass a broad-based category of a symptom of pain in the region of the head or neck. For those patients who unfortunately do not obtain relief from conservative treatment, interventional techniques have been developed and are continuing to be refined in an attempt to treat this subset of patients with the goal of return of daily activities. This investigation reviews various categories of headaches, their pathophysiology, and types of interventional treatments currently available. RECENT
FINDINGS: Injection of botulinum toxin has been shown to increase the number of headache free days for patients suffering from chronic tension-type headaches. Suboccipital steroid injection has been demonstrated as a successful treatment option for patients suffering from cluster headache. Occipital nerve stimulation (ONS) has been described as a treatment for all types of trigeminal autonomic cephalgias. Percutaneous ONS is a minimally invasive and reversible approach to manage occipital neuralgia performed utilizing subcutaneous electrodes placed superficial to the cervical muscular fascia in the suboccipital area. Radiofrequency lesioning is another commonly used treatment in the management of chronic pain syndromes of the head and neck. If a diagnostic sphenopalatine ganglion block successfully resolves the patient's symptoms, neurolysis can be employed as a more permanent solution. Although many patients who suffer from headaches can be treated with conservative, less-invasive treatments, there still remains at present an ever-increasing need for those patients who are refractory to conservative measures and thus require interventional treatments. These procedures are continually evolving to become safer, more precise, and more readily available for clinicians to provide to their patients.

Entities:  

Keywords:  Botulism toxin; Headache; Occipital nerve stimulation; Sphenopalatine ganglion block; Suboccipital steroid injection; Trigeminal autonomic cephalgias

Mesh:

Substances:

Year:  2018        PMID: 29556851     DOI: 10.1007/s11916-018-0681-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  63 in total

1.  Radiofrequency neurotomy for the treatment of third occipital headache.

Authors:  J Govind; W King; B Bailey; N Bogduk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 2.  Post-dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology.

Authors:  David Bezov; Richard B Lipton; Sait Ashina
Journal:  Headache       Date:  2010-06-01       Impact factor: 5.887

3.  Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.

Authors:  Corrie L Graboski; D Shaun Gray; Robert S Burnham
Journal:  Pain       Date:  2005-10-03       Impact factor: 6.961

Review 4.  Atraumatic lumbar puncture needles: after all these years, are we still missing the point?

Authors:  Katherine Arendt; Bart M Demaerschalk; Dean M Wingerchuk; William Camann
Journal:  Neurologist       Date:  2009-01       Impact factor: 1.398

5.  The effectiveness of neurolytic block of sphenopalatine ganglion using zygomatic approach for the management of trigeminal neuropathy.

Authors:  Malgorzata Malec-Milewska; Bartosz Horosz; Dariusz Kosson; Agnieszka Sekowska; Hanna Kucia
Journal:  Neurol Neurochir Pol       Date:  2015-09-19       Impact factor: 1.621

Review 6.  The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.

Authors:  Rebecca C Burch; Stephen Loder; Elizabeth Loder; Todd A Smitherman
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

7.  Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Authors:  R Norman Harden; Jerod Cottrill; Christine M Gagnon; Todd A Smitherman; Stephan R Weinland; Beverley Tann; Petra Joseph; Thomas S Lee; Timothy T Houle
Journal:  Headache       Date:  2008-10-24       Impact factor: 5.887

8.  Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).

Authors:  Terese T Horlocker; Denise J Wedel; John C Rowlingson; F Kayser Enneking; Sandra L Kopp; Honorio T Benzon; David L Brown; John A Heit; Michael F Mulroy; Richard W Rosenquist; Michael Tryba; Chun-Su Yuan
Journal:  Reg Anesth Pain Med       Date:  2010 Jan-Feb       Impact factor: 6.288

9.  Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response.

Authors:  C Z Hong
Journal:  Am J Phys Med Rehabil       Date:  1994 Jul-Aug       Impact factor: 2.159

10.  Spontaneous intracranial hypotension: the syndrome and its complications.

Authors:  James R Couch
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.598

View more
  2 in total

1.  Localization of the Center of the Intramuscular Nerve Dense Region of the Suboccipital Muscles: An Anatomical Study.

Authors:  Jie Wang; Yanrong Li; Meng Wang; Shengbo Yang
Journal:  Front Neurol       Date:  2022-04-06       Impact factor: 4.003

2.  Care Among Migraine Patients in a Commercially Insured Population.

Authors:  Machaon Bonafede; Donna McMorrow; Virginia Noxon; Pooja Desai; Sandhya Sapra; Stephen Silberstein
Journal:  Neurol Ther       Date:  2020-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.